Targeted next-generation sequencing technology showed great potential in identifying spinal tuberculosis and predicting the drug resistance

J Infect. 2023 Dec;87(6):e110-e112. doi: 10.1016/j.jinf.2023.10.018. Epub 2023 Oct 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / pharmacology
  • Antitubercular Agents / therapeutic use
  • Drug Resistance
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Mycobacterium tuberculosis* / genetics
  • Technology
  • Tuberculosis, Multidrug-Resistant* / diagnosis
  • Tuberculosis, Multidrug-Resistant* / drug therapy
  • Tuberculosis, Spinal* / diagnosis

Substances

  • Antitubercular Agents